ISCHEMIA Trial and the Significance of MI
During the past decade, the treatment of choice for chronic coronary syndromes (CCS) has been a contentious issue. Whether revascularisation, either percutaneous or surgical, or optimal medical therapy, offers better prognosis in terms of mortality, MI, and symptom relief, has yet to be confirmed. T...
Saved in:
| Main Authors: | Eduardo A Arias, Félix Damas-de los Santos, Heriberto Ontiveros-Mercado |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2020-10-01
|
| Series: | Interventional Cardiology: Reviews, Research, Resources |
| Online Access: | https://www.icrjournal.com/articles/ischemia-trial-and-the-significance-of-mi |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The ISCHEMIA Trial: What is the Message for the Interventionalist?
by: Emmanuel Ako, et al.
Published: (2021-06-01) -
ISCHEMIA Trial: Key Questions and Answers
by: Jose Lopez-Sendon, et al.
Published: (2021-09-01) -
The expression and significance of miR-378a in oral squamous cell carcinoma
by: CHEN Yan, et al.
Published: (2023-04-01) -
Clinical significance and regulatory mechanism of miR-134-5p in rheumatic heart disease
by: Liangqin Yang, et al.
Published: (2025-08-01) -
Pharmacotherapy in Stable Coronary Artery Disease: Historical Perspectives and New Insights from the ISCHEMIA Trial
by: Jonathan Yap, et al.
Published: (2021-03-01)